首页 | 本学科首页   官方微博 | 高级检索  
检索        

SIRT1/eNOS/NO通路在人参皂苷Rb1抗内皮细胞复制性衰老中的作用
引用本文:周彬,余舒杰,刘定辉,吴琳,王敏,柯世业,刘勇,郝宝顺,朱洁明,钱孝贤.SIRT1/eNOS/NO通路在人参皂苷Rb1抗内皮细胞复制性衰老中的作用[J].中国病理生理杂志,2018,34(10):1762-1768.
作者姓名:周彬  余舒杰  刘定辉  吴琳  王敏  柯世业  刘勇  郝宝顺  朱洁明  钱孝贤
作者单位:1. 中山大学附属第三医院心血管内科, 广东 广州 510630;
2. 中山大学中西医结合研究所, 广东 广州 510630
基金项目:国家自然科学基金资助项目(No.81370447);广东省医学科研基金资助项目(No.A2017014)
摘    要:目的:观察人参皂苷Rb1延缓人脐静脉内皮细胞(HUVECs)复制性衰老的作用,并探讨SIRT1/e NOS/NO通路在其中的作用机制。方法:建立原代HUVECs复制性衰老模型,根据细胞形态的变化、衰老相关β-半乳糖苷酶(SA-β-Gal)染色阳性率和纤溶酶原激活物抑制剂1(PAI-1)的表达水平评估HUVECs衰老情况;采用real-time PCR方法和Western blot法检测沉默SIRT1前后衰老细胞中e NOS和PAI-1的mRNA和蛋白表达,并检测细胞上清NO的含量。结果:累积细胞群体倍增水平(CPDL)为16的HUVECs可作为复制性衰老模型; 80μmol/L人参皂苷Rb1处理后衰老细胞内SIRT1和eNOS的mRNA及蛋白表达水平增加,NO含量增加(P 0. 05),而PAI-1的mRNA和蛋白表达水平下降(P 0. 05);沉默SIRT1后,衰老细胞内e NOS的mRNA及蛋白表达减少,PAI-1的mRNA及蛋白表达增加,NO含量减少(P 0. 05);与SIRT1沉默组比较,在沉默SIRT1基础上加用人参皂苷Rb1后,e NOS和PAI-1表达水平及NO的含量未见明显变化。结论:人参皂苷Rb1可通过调控SIRT1/e NOS/NO通路延缓HUVECs复制性衰老。

关 键 词:人参皂苷Rb1  SIRT1/eNOS/NO信号通路  人脐静脉内皮细胞  复制性衰老  纤溶酶原激活物抑制剂1  
收稿时间:2018-06-15

Role of SIRT1/eNOS/NO signaling pathway in protective effect of ginsenoside Rb1 against replicative senescence of endothelial cells
ZHOU Bin,YU Shu-jie,LIU Ding-hui,WU Lin,WANG Min,KE Shi-ye,LIU Yong,HAO Bao-shun,ZHU Jie-ming,QIAN Xiao-xian.Role of SIRT1/eNOS/NO signaling pathway in protective effect of ginsenoside Rb1 against replicative senescence of endothelial cells[J].Chinese Journal of Pathophysiology,2018,34(10):1762-1768.
Authors:ZHOU Bin  YU Shu-jie  LIU Ding-hui  WU Lin  WANG Min  KE Shi-ye  LIU Yong  HAO Bao-shun  ZHU Jie-ming  QIAN Xiao-xian
Institution:1. Department of Cardiology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, China;
2. Institute of Integrated Traditional Chinese and Western Medicine, Sun Yat-sen University, Guangzhou 510630, China
Abstract:AIM: To explore the effect of ginsenoside Rb1 on replicative senescence of endothelial cells and the role of SIRT1/eNOS/NO signaling pathway in this process. METHODS: The replicative senescence model of primary human umbilical vein endothelial cells (HUVECs) was established. The morphological change of the cells, the proportion of senescence-associated β-galactosidase (SA-β-Gal) positive cells and the plasminogen activator inhibitor 1 (PAI-1) expression were detected to assess the senescence model. The expression of eNOS and PAI-1 at mRNA and protein levels in the aging cells was determined by real-time PCR and Western blot before and after silencing of SIRT1 was performed. The NO concentration in the cell culture supernatant was measured by nitrate reductase assay. RESULTS: HUVECs with cumulative population-doubling level (CPDL) at 16 were chosen as the replicative senescence model in this research. Ginsenoside Rb1 at 80 μmol/L significantly reduced the expression of PAI-1 at mRNA and protein levels. Furthermore, ginsenoside Rb1 increased the expression of SIRT1 and eNOS at mRNA and protein levels, and increased the NO content. SIRT1 silencing inhibited the expression of eNOS at mRNA and protein levels and reduced NO generation, leading to an increase in the expression of PAI-1 at mRNA and protein levels. Upon intervention of ginsenoside Rb1, the eNOS and PAI-1 expression and the level of NO were not reversed. CONCLUSION: Ginsenoside Rb1 modulates SIRT1/eNOS/NO signaling pathway to prevent the replicative senescence of HUVECs.
Keywords:Ginsenoside Rb1  SIRT1/eNOS/NO signaling pathway  Human umbilical vein endothelial cells  Replicative senescence  Plasminogen activator inhibitor 1
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号